Ludivine Morisset

800 total citations
9 papers, 322 citations indexed

About

Ludivine Morisset is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Ludivine Morisset has authored 9 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Ludivine Morisset's work include Advanced Breast Cancer Therapies (4 papers), Cancer-related Molecular Pathways (3 papers) and Estrogen and related hormone effects (2 papers). Ludivine Morisset is often cited by papers focused on Advanced Breast Cancer Therapies (4 papers), Cancer-related Molecular Pathways (3 papers) and Estrogen and related hormone effects (2 papers). Ludivine Morisset collaborates with scholars based in France, United Kingdom and Italy. Ludivine Morisset's co-authors include Marie-Claire Gübler, Corinne Antignac, Vasiliki Kalatzis, Olivier Devuyst, Marie Chol, Nathalie Névo, Elisabetta Marangoni, Olivia Boyer, Laura Sourd and Andrea Onetti Muda and has published in prestigious journals such as Cancer Research, Oncogene and Journal of the American Society of Nephrology.

In The Last Decade

Ludivine Morisset

9 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ludivine Morisset France 7 131 97 96 87 78 9 322
Haruhiko Hirai Japan 8 155 1.2× 39 0.4× 38 0.4× 35 0.4× 78 1.0× 16 337
Feng Luo China 11 188 1.4× 58 0.6× 38 0.4× 169 1.9× 33 0.4× 20 390
Yoshiya Ohno Japan 10 109 0.8× 69 0.7× 14 0.1× 23 0.3× 18 0.2× 17 234
Yingwei Xue China 12 195 1.5× 149 1.5× 32 0.3× 76 0.9× 8 0.1× 27 406
Jana Soukupová Czechia 12 210 1.6× 110 1.1× 104 1.1× 28 0.3× 20 0.3× 38 467
Jian Chang United States 7 187 1.4× 145 1.5× 57 0.6× 44 0.5× 51 0.7× 10 460
Jen‐Tai Lin Taiwan 8 304 2.3× 89 0.9× 23 0.2× 116 1.3× 6 0.1× 24 575
Amit Bera United States 13 311 2.4× 33 0.3× 16 0.2× 35 0.4× 99 1.3× 15 409
Do‐Sun Byun South Korea 8 381 2.9× 127 1.3× 75 0.8× 58 0.7× 5 0.1× 8 507
Najeeba Ali United States 5 188 1.4× 177 1.8× 18 0.2× 79 0.9× 5 0.1× 6 363

Countries citing papers authored by Ludivine Morisset

Since Specialization
Citations

This map shows the geographic impact of Ludivine Morisset's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ludivine Morisset with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ludivine Morisset more than expected).

Fields of papers citing papers by Ludivine Morisset

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ludivine Morisset. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ludivine Morisset. The network helps show where Ludivine Morisset may publish in the future.

Co-authorship network of co-authors of Ludivine Morisset

This figure shows the co-authorship network connecting the top 25 collaborators of Ludivine Morisset. A scholar is included among the top collaborators of Ludivine Morisset based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ludivine Morisset. Ludivine Morisset is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Pottier, Charles, Dominique Baiwir, Gabriel Mazzucchelli, et al.. (2025). Targeting ferroptosis resistance resensitizes metastatic HR + HER2 − breast cancer cells to palbociclib‐hormone therapy. Cancer Communications. 45(4). 460–464. 1 indexed citations
2.
Iravani, Marjan, Rania El Botty, John Alexander, et al.. (2023). Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast Cancers. Cancer Research. 84(1). 17–25. 6 indexed citations
3.
Jacquemetton, Julien, Loay Kassem, Coralie Poulard, et al.. (2021). Analysis of genomic and non-genomic signaling of estrogen receptor in PDX models of breast cancer treated with a combination of the PI3K inhibitor alpelisib (BYL719) and fulvestrant. Breast Cancer Research. 23(1). 57–57. 12 indexed citations
4.
Simões, Bruno M., Angélica Santiago-Gómez, Daniel Conole, et al.. (2020). Targeting STAT3 signaling using stabilised sulforaphane (SFX-01) inhibits endocrine resistant stem-like cells in ER-positive breast cancer. Oncogene. 39(25). 4896–4908. 33 indexed citations
5.
Pancholi, Sunil, Ricardo Ribas, Nikiana Simigdala, et al.. (2020). Tumour kinome re-wiring governs resistance to palbociclib in oestrogen receptor positive breast cancers, highlighting new therapeutic modalities. Oncogene. 39(25). 4781–4797. 63 indexed citations
6.
Coussy, Florence, Rania El Botty, Laetitia Fuhrmann, et al.. (2020). Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers. Journal of Hematology & Oncology. 13(1). 13–13. 43 indexed citations
7.
Névo, Nathalie, Marie Chol, Vasiliki Kalatzis, et al.. (2009). Renal phenotype of the cystinosis mouse model is dependent upon genetic background. Nephrology Dialysis Transplantation. 25(4). 1059–1066. 77 indexed citations
8.
Mollet, Géraldine, Julien Ratelade, Olivia Boyer, et al.. (2009). Podocin Inactivation in Mature Kidneys Causes Focal Segmental Glomerulosclerosis and Nephrotic Syndrome. Journal of the American Society of Nephrology. 20(10). 2181–2189. 71 indexed citations
9.
Ratelade, Julien, Andrea Onetti Muda, Ludivine Morisset, et al.. (2008). Maternal Environment Interacts with Modifier Genes to Influence Progression of Nephrotic Syndrome. Journal of the American Society of Nephrology. 19(8). 1491–1499. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haruhiko Hirai Breakdown of academic impact, for papers by Feng Luo Breakdown of academic impact, for papers by Yoshiya Ohno Breakdown of academic impact, for papers by Yingwei Xue Breakdown of academic impact, for papers by Jana Soukupová Breakdown of academic impact, for papers by Jian Chang Breakdown of academic impact, for papers by Jen‐Tai Lin Breakdown of academic impact, for papers by Amit Bera Breakdown of academic impact, for papers by Do‐Sun Byun Breakdown of academic impact, for papers by Najeeba Ali
Rankless by CCL
2026